Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.

A series of 2-substituted amino-3-chloro-1,4-naphthoquinone derivatives (3-12) were synthesized as anticancer agents and tested against four cancer cell lines including HepG2, HuCCA-1, A549 and MOLT-3. The most potent cytotoxic activity against the HepG2, HuCCA-1 and A549 cell lines was found to be m-acetylphenylamino-1,4-naphthoquinone (8) affording IC50 values of 4.758, 2.364 and 12.279 μM, respectively. On the other hand, p-acetylphenylamino-1,4-naphthoquinone (9) exhibited the most potent cytotoxic activity against the MOLT-3 cell line with an IC50 of 2.118 μM. Quantitative structure-activity relationship (QSAR) investigations provided good predictive performance as observed from cross-validated R of 0.9177-0.9753 and RMSE of 0.0614-0.1881. The effects of substituents at the 2-amino position on the naphthoquinone core structure and its corresponding influence on the cytotoxic activity were investigated by virtually constructing additional 1,4-naphthoquinone compounds (13-36) for which cytotoxic activities were predicted using equations obtained from the previously constructed QSAR models. Interpretation of informative descriptors from QSAR models revealed pertinent knowledge on physicochemical properties governing the cytotoxic activities of tested cancer cell lines. It is anticipated that the QSAR models developed herein could provide guidelines for further development of novel and potent anticancer agents.

[1]  J. Champoux DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[2]  J. Benites,et al.  Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents. , 2010, European journal of medicinal chemistry.

[3]  P. Mailley,et al.  Electrochemistry and bioactivity relationship of 6-substituted-4H-pyrido[4,3,2-kl]acridin-4-one antitumor drug candidates. , 2012, Bioelectrochemistry.

[4]  C. Hansch,et al.  Elucidation of structure-activity relationships for 2- or 6-substituted-5,8-dimethoxy-1,4-naphthoquinones. , 2004, Bioorganic & medicinal chemistry.

[5]  P. Shukla,et al.  2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents. , 2009, European journal of medicinal chemistry.

[6]  Claus Jacob,et al.  Deciphering intracellular targets of organochalcogen based redox catalysts , 2012 .

[7]  N. Osheroff,et al.  Etoposide quinone is a redox-dependent topoisomerase II poison. , 2011, Biochemistry.

[8]  Sheng-Tung Huang,et al.  Efficient synthesis of 'redox-switched' naphthoquinone thiol-crown ethers and their biological activity evaluation. , 2002, Bioorganic & medicinal chemistry.

[9]  J. Minna,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. , 1987, Cancer research.

[10]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[11]  K. C. Majumdar,et al.  Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. , 1977, Biochemical and biophysical research communications.

[12]  J. Raffetto,et al.  The structure of streptonigrin semiquinone in solution. , 1997, Biochimica et biophysica acta.

[13]  B. Cavalcanti,et al.  1,2,3-triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones. , 2014, Bioorganic & medicinal chemistry.

[14]  P. O'Brien Molecular mechanisms of quinone cytotoxicity. , 1991, Chemico-biological interactions.

[15]  S. Kuo,et al.  Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents. , 2002, Chemical & pharmaceutical bulletin.

[16]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[17]  Y. Yun,et al.  Inhibitory Effects of J78, a Newly Synthesized 1,4-Naphthoquinone Derivative, on Experimental Thrombosis and Platelet Aggregation , 2004, Pharmacology.

[18]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[19]  Chartchalerm Isarankura-Na-Ayudhya,et al.  Advances in computational methods to predict the biological activity of compounds , 2010, Expert opinion on drug discovery.

[20]  L. Liu,et al.  Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[21]  Daniel N. Santiago,et al.  Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors. , 2010, Bioorganic & medicinal chemistry.

[22]  S. Kaufmann Cell death induced by topoisomerase-targeted drugs: more questions than answers. , 1998, Biochimica et biophysica acta.

[23]  N. Osheroff Eukaryotic topoisomerase II. Characterization of enzyme turnover. , 1986, The Journal of biological chemistry.

[24]  C. Nantasenamat,et al.  QSAR study of amidino bis-benzimidazole derivatives as potent anti-malarial agents against Plasmodium falciparum , 2013, Chemical Papers.

[25]  Corwin Hansch,et al.  QSAR and ADME. , 2004, Bioorganic & medicinal chemistry.

[26]  B. J. Roberts,et al.  Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues. , 1984, Cancer research.

[27]  E. Shults,et al.  Inhibition of HIV-1 Reverse Transcriptase by Aryl-Substituted Naphto- and Anthraquinones , 2004, Doklady Biochemistry and Biophysics.

[28]  A. Hakura,et al.  Mutagenicity and cytotoxicity of naphthoquinones for Ames Salmonella tester strains. , 1994, Chemical research in toxicology.

[29]  K. Hande,et al.  Topoisomerase II inhibitors. , 2006, Cancer chemotherapy and biological response modifiers.

[30]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[31]  Apilak Worachartcheewan,et al.  Predicting antimicrobial activities of benzimidazole derivatives , 2013, Medicinal Chemistry Research.

[32]  N. Osheroff,et al.  DNA topoisomerase II, genotoxicity, and cancer. , 2007, Mutation research.

[33]  Garry R. Buettner,et al.  Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide. , 2010, Free radical biology & medicine.

[34]  Pui-Kai Li,et al.  Anticancer activity and SAR studies of substituted 1,4-naphthoquinones. , 2013, Bioorganic & medicinal chemistry.

[35]  N. Osheroff,et al.  Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes. , 2003, Current topics in medicinal chemistry.

[36]  T. Hamamoto,et al.  A water-soluble tetrazolium salt useful for colorimetric cell viability assay , 1999 .

[37]  C. Ryu,et al.  The synthesis and antimicrobial activities of some 1,4-naphthoquinones (II) , 1992 .

[38]  R. Hickey,et al.  Synthesis and preliminary pharmacological evaluation of new (+/-) 1,4-naphthoquinones structurally related to lapachol. , 2002, Bioorganic & medicinal chemistry.

[39]  V. K. Tandon,et al.  Design, synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antifungal and anticancer agents. , 2004, Bioorganic & medicinal chemistry letters.

[40]  V. B. Konkimalla,et al.  Synthesis, characterization and molecular structures of homologated analogs of 2-bromo-3-(n-alkylamino)-1,4-napthoquinone , 2014 .

[41]  C. Avendaño,et al.  DNA Intercalators and Topoisomerase Inhibitors , 2008 .

[42]  P. Shukla,et al.  Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents. , 2009, European journal of medicinal chemistry.

[43]  G M Cohen,et al.  Quinone chemistry and toxicity. , 1992, Toxicology and applied pharmacology.

[44]  Y. Yun,et al.  Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. , 2000, Biochemical pharmacology.

[45]  C. Nantasenamat,et al.  Antioxidant, cytotoxicity, and QSAR study of 1-adamantylthio derivatives of 3-picoline and phenylpyridines , 2011, Medicinal Chemistry Research.

[46]  J. Bolton,et al.  Role of quinones in toxicology. , 2000, Chemical research in toxicology.

[47]  D. Hunting,et al.  The ortho-quinone metabolite of the anticancer drug etoposide (VP-16) is a potent inhibitor of the topoisomerase II/DNA cleavable complex. , 1998, Molecular pharmacology.

[48]  A. Oliveira,et al.  Trypanocidal activity and redox potential of heterocyclic- and 2-hydroxy-naphthoquinones , 1997 .

[49]  R. Verma Anti-cancer activities of 1,4-naphthoquinones: a QSAR study. , 2006, Anti-cancer agents in medicinal chemistry.

[50]  B. Ahn,et al.  Naphthazarin derivatives (VIII): Synthesis, inhibitory effect on DNA topoisomerase‐I, and antiproliferative activity of 6‐(1‐acyloxyalkyl)‐5,8‐dimethoxy‐1,4‐naphthoquinones , 2001, Archiv der Pharmazie.

[51]  N. Osheroff,et al.  Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. , 2000, Progress in nucleic acid research and molecular biology.

[52]  F. Yoshizaki,et al.  In vitro antifungal activity of naphthoquinone derivatives. , 2002, Biological & pharmaceutical bulletin.

[53]  Christian Amatore,et al.  Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds. , 2008, Chemical communications.

[54]  P. Shukla,et al.  Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents. , 2006, Bioorganic & medicinal chemistry.

[55]  C. Chignell,et al.  Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. , 2004, Chemical research in toxicology.

[56]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .

[57]  J. B. Griffiths,et al.  Mammalian cell culture : essential techniques , 1997 .

[58]  V. Yardley,et al.  2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. , 2001, Journal of medicinal chemistry.

[59]  H. Schwalbe,et al.  Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol/fumarate reductase from Wolinella succinogenes. , 2013, Journal of medicinal chemistry.

[60]  Mark A. Hall,et al.  Correlation-based Feature Selection for Machine Learning , 2003 .

[61]  L. Pardo,et al.  Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line. , 2007, Journal of medicinal chemistry.

[62]  P. Shukla,et al.  Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents. , 2005, Bioorganic & medicinal chemistry letters.

[63]  F. Emery,et al.  Synthesis of quinoidal molecules: strategies towards bioactive compounds with an emphasis on lapachones. , 2013, European journal of medicinal chemistry.

[64]  Chartchalerm Isarankura-Na-Ayudhya,et al.  A practical overview of quantitative structure-activity relationship , 2009 .